Selloff or Market Correction? Either Way, Here's What to Do NextSee Overvalued Stocks

FDA orders R.J. Reynolds to cease menthol e-cigarette sales amid health concerns

EditorRachael Rajan
Published 10/13/2023, 02:44 PM
© Reuters.

In a move aiming to curb youth vaping and address health risks, the U.S. Food and Drug Administration (FDA) ordered R.J. Reynolds to stop the sale of its Vuse Alto menthol e-cigarettes on Friday. This directive has led to a court challenge from British American Tobacco (NYSE:BTI), the parent company of Reynolds. However, this order will not affect the sales of Reynolds' tobacco-flavored products.

The FDA is also expected to impose a ban on all menthol cigarettes, including Newports, which generate annual sales of $7.5 billion. Despite these bans, manufacturers like Juul will be permitted to continue selling their products during litigation.

According to data from Goldman Sachs, menthol vapes account for 29% ($1.6 billion) of the U.S. e-cigarette market, with Vuse products making up 40% of that segment. It was noted that Vuse vapes are particularly popular among middle and high school students.

In response to the FDA's decision, The Campaign for Tobacco-Free Kids expressed support, while Reynolds challenged California's recent ban on flavored tobacco. Reynolds criticized the FDA for permitting vapor products with youth-appealing flavors like Cotton Candy and Peanut Butter Cookie to remain on sale.

Previously, Reynolds voluntarily halted the sale of its mixed berry flavor. Dr. Alex Liber suggested that bans on flavored-vape could potentially lead to an increase in cigarette sales in a market already saturated with illicit products.

British American Tobacco emphasized its commitment to the rule of law in regulated markets and criticized the proliferation of youth-appealing flavors in the industry. Meanwhile, California's state attorney general issued a warning against cooling flavor products amidst the ongoing youth e-cigarette crisis.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.